Childhood attention-deficit/hyperactivity disorder (ADHD) is associated with impaired cognitive functioning in adulthood.

Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes.

Emotional dysregulation is more severe among individuals with ASD than neurotypical peers and those with other clinical conditions.

COVID-19 vaccination was associated with a lower incidence of mental illnesses, like depression, following COVID-19 infection.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

There was no significant difference in functional dependency or death at 90 days between patients with single subcortical infarction only who received early vs delayed antihypertensive treatment.

Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia.

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.